Question 1

What are the key details for the project “Granules”?

Accepted Answer

The project “Granules” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in India. Taiyo aggregates data on it from International Finance Corporation (IFC).

Question 2

What is the latest status of the project “Granules”?

Accepted Answer

The status recorded for “Granules” is completed.

Question 3

Who are the main government, EPC, and private stakeholders for “Granules”?

Accepted Answer

Taiyo maps the stakeholders of “Granules”: government bodies (International Finance Corporation (IFC)).

Question 4

What is the budget and commercial profile for the project “Granules”?

Accepted Answer

The procurement structure is Public-Private Partnership (PPP).

Question 5

Where can I verify the source and access all details for “Granules”?

Accepted Answer

This Taiyo project page references International Finance Corporation (IFC) along with the original URL (https://disclosures.ifc.org/project-detail/SPI/25947/granules). Taiyo standardizes official data into a consistent, searchable project profile.

Sponsoring Agency	Obfuscated Data
Company	Obfuscated Data

Original status	completed
Taiyo status	Obfuscated Data
Taiyo last update	00-00-0000
Available timestamps	00-00-0000
Available timestamp type	Obfuscated Data

Contact name	Obfuscated Data
Phone	0000000000
Email	ObfuscatedData@email.com
Address	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description	Granules India Limited (Granules or the company) is a leading Contract Manufacturing Organization supplying high volume Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Formulation Intermediates (PFIs) to the bulk over-the-counter (OTC) drugs industry in the US, Europe, Latin America, Australia and India. Granules has three wholly-owned manufacturing plants in India and one plant in China through a 50:50 joint venture (JV). The company is undertaking an investment program estimated to cost about $32 million, comprising of: - setting up a 6 billion per annum multi-product tableting plant; - setting up a 3,600 TPA paracetamol API plant;- installing an additional 3,600TPA of paracetamol PFI capacity; - investment in a JV in China for ibuprofen API with a capacity of 3,800TPA; and - development and registration of new products.
Original sub-sector	Obfuscated
Original Currency	USD
Original budget	000000000000000
Procurement method	Obfuscated Data
Budget	000000000000000

Region	Obfuscated
Country	Obfuscated
State	Obfuscated Data
County	Obfuscated
Location	Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source reliability	High
Data quality score	100%
Source	Obfuscated Data
URL	obfuscated_data,obfuscateddata.com

Project Type	Obfuscated Data
Article Published Date	Obfuscated Data

Granules

Project Information FAQ

Project Information